Latest Non Dilutive Funding News

Ariana Resources has monetised part of its Zenit holding for US$19.5 million cash, retaining a 9.9% stake and boosting its war chest to advance the Dokwe Gold Project feasibility study in Zimbabwe.

Lumos Diagnostics has reached a key enrolment milestone in its BARDA-backed FebriDx paediatric trial, unlocking a US$670,000 payment and advancing its FDA submission pathway to expand use in children aged 2-12 years.

Alicanto Minerals has struck strategic earn-in agreements for its Swedish projects potentially worth A$21 million, while expanding its Mt Henry Gold Project footprint in Western Australia and proposing a name change to Sinclair Gold.

Nexsen has secured a strategic partnership with GHK Hospital Limited in Hong Kong, marking a significant step in validating and commercialising its rapid point-of-care diagnostics across North Asia.

Anson Resources' US arm, A1 Lithium, secures membership in a key US defense consortium, boosting government ties and funding prospects. Its Yellow Cat project earns a positive technical feasibility rating, aligning with US critical minerals priorities.

EMVision is broadening its emu™ Pivotal Trial to include acute ischaemia detection, aiming to accelerate FDA clearance and enhance the brain scanner's clinical impact. Recruitment has passed 125 patients across US and Australian sites, with full enrolment expected by early 2027.

Litchfield Minerals denies undisclosed material information behind recent share price jump, pointing to public engagement, media activity, and early-stage exploration sample processing as key influences.

Nexsen Limited teams with Universiti Malaya to launch a joint research facility aiming to develop a rapid biosensor detecting E. coli and Salmonella simultaneously, addressing a critical food safety gap in Southeast Asia.

GoldArc Resources has secured full ownership of Mt Stirling and launched partner-funded drilling campaigns across its Leonora North and South projects, delivering multiple high-grade gold results and locking in a binding development deal with Mineral Mining Services.

Recce Pharmaceuticals bolsters its clinical and commercial pipeline with a $5.3 million AUD R&D tax rebate, a second U.S. Army research agreement for its RECCE 327 Gel, and a key patent granted in Brazil, while progressing Phase 3 trials in Indonesia.

Chariot Resources advances its Nigerian lithium acquisition with six licences transferred and spodumene confirmed in samples, while raising A$2.15 million and securing a A$3.5 million loan refinancing.

Titomic Limited is gearing up for a strategic shift to the US with a planned redomicile in H2 2026, while clinching major contracts across aerospace, defense, and rail sectors and achieving critical certifications that underpin its manufacturing ambitions.